Patients with certain chronic diseases will soon face a new significant increase in drug prices, reaching up to ten times what they currently pay, especially for medications classified as D and E1, E2 with prices ranging from $100 to $700.

The price difference has prompted the Ministry of Public Health to look for alternatives by increasing the prices of medications dispensed by insurance funds to patients not covered by the ministry and not included in the new Ministry-approved tracking system.

The decision, if implemented, will include many medications, including kidney transplant drugs, dangerous fungal medications administered in hospitals, cancer drugs outside treatment protocols, and others.